{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:36:26Z","timestamp":1793090186270,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T00:00:00Z","timestamp":1559520000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T00:00:00Z","timestamp":1559520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"ANR","award":["ANR-10-LABX-46"],"award-info":[{"award-number":["ANR-10-LABX-46"]}]},{"name":"Fonds hospitalier d\u2019aide \u00e0 l\u2019\u00e9mergence et \u00e0 la structuration des activit\u00e9s et des \u00e9quipes de recherche","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"ERC","award":["694717"],"award-info":[{"award-number":["694717"]}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12920-019-0536-1","type":"journal-article","created":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T11:03:26Z","timestamp":1559559806000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Hepatic transcriptomic signatures of statin treatment are associated with impaired glucose homeostasis in severely obese patients"],"prefix":"10.1186","volume":"12","author":[{"given":"Daniel","family":"Margerie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta","family":"Raverdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Schwahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Ruetten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Duhamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Labreuche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doroth\u00e9e","family":"Thuillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Derudas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Gheeraert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Dehondt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Dhalluin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9my","family":"Alexandre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Caiazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Nesslany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Verkindt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Pattou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3784-1503","authenticated-orcid":false,"given":"Bart","family":"Staels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,3]]},"reference":[{"issue":"9841","key":"536_CR1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","volume":"380","author":"B Mihaylova","year":"2012","unstructured":"Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380(9841):581\u201390.","journal-title":"Lancet."},{"issue":"4","key":"536_CR2","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/hep.20671","volume":"41","author":"N Chalasani","year":"2005","unstructured":"Chalasani N. Statins and hepatotoxicity: focus on patients with fatty liver. Hepatology. 2005;41(4):690\u20135.","journal-title":"Hepatology."},{"issue":"23","key":"536_CR3","first-page":"III50","volume":"109","author":"S Bellosta","year":"2004","unstructured":"Bellosta S, Paoletti R, Corsini A. Safety of statins: focus on clinical pharmacokinetics and drug interactions. Circulation. 2004;109(23 Suppl 1):III50\u20137.","journal-title":"Circulation."},{"issue":"360","key":"536_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.tox.2016.06.015","volume":"359","author":"SO El-Ganainy","year":"2016","unstructured":"El-Ganainy SO, El-Mallah A, Abdallah D, Khattab MM, Mohy El-Din MM, El-Khatib AS. Elucidation of the mechanism of atorvastatin-induced myopathy in a rat model. Toxicology. 2016;359(360):29\u201338.","journal-title":"Toxicology."},{"issue":"2","key":"536_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jacc.2012.09.042","volume":"61","author":"DD Waters","year":"2013","unstructured":"Waters DD, Ho JE, Boekholdt SM, DeMicco DA, Kastelein JJ, Messig M, et al. Cardiovascular event reduction versus new-onset diabetes during atorvastatin therapy: effect of baseline risk factors for diabetes. J Am Coll Cardiol. 2013;61(2):148\u201352.","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"536_CR6","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1001\/jama.2011.860","volume":"305","author":"D Preiss","year":"2011","unstructured":"Preiss D, Seshasai SR, Welsh P, Murphy SA, Ho JE, Waters DD, et al. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA. 2011;305(24):2556\u201364.","journal-title":"JAMA."},{"issue":"9841","key":"536_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(12)61190-8","volume":"380","author":"PM Ridker","year":"2012","unstructured":"Ridker PM, Pradhan A, MacFadyen JG, Libby P, Glynn RJ. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet. 2012;380(9841):565\u201371.","journal-title":"Lancet"},{"issue":"1","key":"536_CR8","doi-asserted-by":"publisher","first-page":"e000438","DOI":"10.1136\/bmjdrc-2017-000438","volume":"5","author":"Jill P Crandall","year":"2017","unstructured":"Crandall JP, Mather K, Rajpathak SN, Goldberg RB, Watson K, Foo S, et al. Statin use and risk of developing diabetes: results from the diabetes prevention program. BMJ Open Diabetes Res Care. 2017;5(1):e000438.","journal-title":"BMJ Open Diabetes Research & Care"},{"issue":"8","key":"536_CR9","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.2337\/dc13-2215","volume":"37","author":"G Corrao","year":"2014","unstructured":"Corrao G, Ibrahim B, Nicotra F, Soranna D, Merlino L, Catapano AL, et al. Statins and the risk of diabetes: evidence from a large population-based cohort study. Diabetes Care. 2014;37(8):2225\u201332.","journal-title":"Diabetes Care"},{"issue":"11","key":"536_CR10","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s11606-015-3335-1","volume":"30","author":"I Mansi","year":"2015","unstructured":"Mansi I, Frei CR, Wang CP, Mortensen EM. Statins and new-onset diabetes mellitus and diabetic complications: a retrospective cohort study of US healthy adults. J Gen Intern Med. 2015;30(11):1599\u2013610.","journal-title":"J Gen Intern Med"},{"issue":"2","key":"536_CR11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1001\/archinternmed.2011.625","volume":"172","author":"AL Culver","year":"2012","unstructured":"Culver AL, Ockene IS, Balasubramanian R, Olendzki BC, Sepavich DM, Wactawski-Wende J, et al. Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative. Arch Intern Med. 2012;172(2):144\u201352.","journal-title":"Arch Intern Med"},{"issue":"5","key":"536_CR12","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.numecd.2017.03.001","volume":"27","author":"M Casula","year":"2017","unstructured":"Casula M, Mozzanica F, Scotti L, Tragni E, Pirillo A, Corrao G, et al. Statin use and risk of new-onset diabetes: a meta-analysis of observational studies. Nutrition, metabolism, and cardiovascular diseases : NMCD. 2017;27(5):396\u2013406.","journal-title":"Nutrition, metabolism, and cardiovascular diseases : NMCD"},{"issue":"8","key":"536_CR13","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1007\/s00125-015-3674-9","volume":"58","author":"H Cederberg","year":"2015","unstructured":"Cederberg H, Laakso M. Variable effects of statins on glucose homeostasis parameters and their diabetogenic role. Reply to Kostapanos MS, Agouridis AP and Elisaf MS [letter]. Diabetologia. 2015;58(8):1962\u20133.","journal-title":"Diabetologia."},{"issue":"10","key":"536_CR14","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/pds.4020","volume":"25","author":"D Thakker","year":"2016","unstructured":"Thakker D, Nair S, Pagada A, Jamdade V, Malik A. Statin use and the risk of developing diabetes: a network meta-analysis. Pharmacoepidemiol Drug Saf. 2016;25(10):1131\u201349.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9716","key":"536_CR15","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","volume":"375","author":"N Sattar","year":"2010","unstructured":"Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJM, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet. 2010;375(9716):735\u201342.","journal-title":"Lancet"},{"issue":"22","key":"536_CR16","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1056\/NEJMoa1604304","volume":"375","author":"BA Ference","year":"2016","unstructured":"Ference BA, Robinson JG, Brook RD, Catapano AL, Chapman MJ, Neff DR, et al. Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes. N Engl J Med. 2016;375(22):2144\u201353.","journal-title":"N Engl J Med"},{"issue":"9965","key":"536_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0140-6736(14)61183-1","volume":"385","author":"DI Swerdlow","year":"2015","unstructured":"Swerdlow DI, Preiss D, Kuchenbaecker KB, Holmes MV, Engmann JEL, Shah T, et al. HMG-coenzyme a reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Lancet. 2015;385(9965):351\u201361.","journal-title":"Lancet"},{"issue":"6","key":"536_CR18","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.metabol.2014.02.014","volume":"63","author":"M Brault","year":"2014","unstructured":"Brault M, Ray J, Gomez YH, Mantzoros CS, Daskalopoulou SS. Statin treatment and new-onset diabetes: a review of proposed mechanisms. Metabolism. 2014;63(6):735\u201345.","journal-title":"Metabolism."},{"issue":"3","key":"536_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/MOL.0000000000000172","volume":"26","author":"JG Robinson","year":"2015","unstructured":"Robinson JG. Statins and diabetes risk: how real is it and what are the mechanisms? Curr Opin Lipidol. 2015;26(3):228\u201335.","journal-title":"Curr Opin Lipidol"},{"issue":"5","key":"536_CR20","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1097\/SLA.0000000000001915","volume":"264","author":"V Raverdy","year":"2016","unstructured":"Raverdy V, Baud G, Pigeyre M, Verkindt H, Torres F, Preda C, et al. Incidence and predictive factors of postprandial Hyperinsulinemic hypoglycemia after roux-en-Y gastric bypass: a five year longitudinal study. Ann Surg. 2016;264(5):878\u201385.","journal-title":"Ann Surg"},{"issue":"5","key":"536_CR21","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1097\/SLA.0000000000000945","volume":"260","author":"R Caiazzo","year":"2014","unstructured":"Caiazzo R, Lassailly G, Leteurtre E, Baud G, Verkindt H, Raverdy V, et al. Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study. Ann Surg. 2014;260(5):893\u20138 discussion 8-9.","journal-title":"Ann Surg"},{"issue":"Suppl 1","key":"536_CR22","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc18-S002","volume":"41","author":"American Diabetes A","year":"2018","unstructured":"American Diabetes A. 2. Classification and diagnosis of diabetes: standards of medical Care in Diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S13\u201327.","journal-title":"Diabetes Care"},{"issue":"12","key":"536_CR23","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.2337\/diacare.21.12.2191","volume":"21","author":"JC Levy","year":"1998","unstructured":"Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998;21(12):2191\u20132.","journal-title":"Diabetes Care"},{"issue":"2","key":"536_CR24","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/pst.433","volume":"10","author":"PC Austin","year":"2011","unstructured":"Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10(2):150\u201361.","journal-title":"Pharm Stat"},{"issue":"6","key":"536_CR25","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1002\/sim.6004","volume":"33","author":"PC Austin","year":"2014","unstructured":"Austin PC. A comparison of 12 algorithms for matching on the propensity score. Stat Med. 2014;33(6):1057\u201369.","journal-title":"Stat Med"},{"issue":"25","key":"536_CR26","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","volume":"28","author":"PC Austin","year":"2009","unstructured":"Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083\u2013107.","journal-title":"Stat Med"},{"key":"536_CR27","doi-asserted-by":"crossref","unstructured":"van Buuren S, Groothuis-Oudshoorn K. mice: Multivariate Imputation by Chained Equations in R 2011 2011;45(3):67.","DOI":"10.18637\/jss.v045.i03"},{"issue":"2","key":"536_CR28","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10260-007-0086-0","volume":"18","author":"A Mattei","year":"2008","unstructured":"Mattei A. Estimating and using propensity score in presence of missing background data: an application to assess the impact of childbearing on wellbeing. JISS. 2008;18(2):257\u201373.","journal-title":"JISS"},{"key":"536_CR29","unstructured":"Rubin DB. Multiple imputation for nonresponse in surveys. Hoboken: Wiley; 2004. ISBN 0-471-65574-0."},{"issue":"10","key":"536_CR30","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/nm1662","volume":"13","author":"T Matsuzaka","year":"2007","unstructured":"Matsuzaka T, Shimano H, Yahagi N, Kato T, Atsumi A, Yamamoto T, et al. Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance. Nat Med. 2007;13(10):1193\u2013202.","journal-title":"Nat Med"},{"issue":"4","key":"536_CR31","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00109-009-0449-0","volume":"87","author":"T Matsuzaka","year":"2009","unstructured":"Matsuzaka T, Shimano H. Elovl6: a new player in fatty acid metabolism and insulin sensitivity. J Mol Med (Berl). 2009;87(4):379\u201384.","journal-title":"J Mol Med (Berl)"},{"key":"536_CR32","doi-asserted-by":"publisher","first-page":"18366","DOI":"10.1038\/srep18366","volume":"5","author":"C Yew Tan","year":"2015","unstructured":"Yew Tan C, Virtue S, Murfitt S, Roberts LD, Phua YH, Dale M, et al. Adipose tissue fatty acid chain length and mono-unsaturation increases with obesity and insulin resistance. Sci Rep. 2015;5:18366.","journal-title":"Sci Rep"},{"issue":"3","key":"536_CR33","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1373\/clinchem.2008.115352","volume":"55","author":"JA Menendez","year":"2009","unstructured":"Menendez JA, Vazquez-Martin A, Ortega FJ, Fernandez-Real JM. Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer. Clin Chem. 2009;55(3):425\u201338.","journal-title":"Clin Chem"},{"issue":"11","key":"536_CR34","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1097\/FPC.0b013e32834a5585","volume":"21","author":"M Hafner","year":"2011","unstructured":"Hafner M, Juvan P, Rezen T, Monostory K, Pascussi JM, Rozman D. The human primary hepatocyte transcriptome reveals novel insights into atorvastatin and rosuvastatin action. Pharmacogenet Genomics. 2011;21(11):741\u201350.","journal-title":"Pharmacogenet Genomics"},{"issue":"3","key":"536_CR35","first-page":"281","volume":"64","author":"L Aguirre","year":"2013","unstructured":"Aguirre L, Hijona E, Macarulla MT, Gracia A, Larrechi I, Bujanda L, et al. Several statins increase body and liver fat accumulation in a model of metabolic syndrome. J Physiol Pharmacol. 2013;64(3):281\u20138.","journal-title":"J Physiol Pharmacol"},{"issue":"12","key":"536_CR36","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/nrendo.2017.91","volume":"13","author":"H Shimano","year":"2017","unstructured":"Shimano H, Sato R. SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology. Nat Rev Endocrinol. 2017;13(12):710\u201330.","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"536_CR37","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cmet.2012.09.002","volume":"16","author":"W Shao","year":"2012","unstructured":"Shao W, Espenshade PJ. Expanding roles for SREBP in metabolism. Cell Metab. 2012;16(4):414\u20139.","journal-title":"Cell Metab"},{"issue":"11","key":"536_CR38","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1111\/j.1872-034X.2008.00382.x","volume":"38","author":"N Higuchi","year":"2008","unstructured":"Higuchi N, Kato M, Shundo Y, Tajiri H, Tanaka M, Yamashita N, et al. Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease. Hepatol Res. 2008;38(11):1122\u20139.","journal-title":"Hepatol Res"},{"issue":"2","key":"536_CR39","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/brv.12178","volume":"91","author":"FW Sanders","year":"2016","unstructured":"Sanders FW, Griffin JL. De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose. Biol Rev Camb Philos Soc. 2016;91(2):452\u201368.","journal-title":"Biol Rev Camb Philos Soc"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-019-0536-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12920-019-0536-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-019-0536-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T23:55:14Z","timestamp":1591055714000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-019-0536-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,3]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["536"],"URL":"https:\/\/doi.org\/10.1186\/s12920-019-0536-1","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,3]]},"assertion":[{"value":"13 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Human liver biopsies were collected from patients undergoing surgery after informed consent was obtained. All procedures were approved by the C.H.R.U. Lille Ethical committee and were compliant to the French National Ethics Committee guidelines. The ABOS cohort is registered at  with the following identifier: NCT01129297.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Drs. Margerie, Schwahn, Ruetten and Larsen are employees and shareholders of Sanofi. All other authors declare no potential conflicts of interest relevant to this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}